| 000 | 01779 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515053242.0 | ||
| 264 | 0 | _c20070604 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0009-9120 | ||
| 024 | 7 |
_a10.1016/j.clinbiochem.2006.10.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRashtchizadeh, Nadereh | |
| 245 | 0 | 0 |
_aEnalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms. _h[electronic resource] |
| 260 |
_bClinical biochemistry _cFeb 2007 |
||
| 300 |
_a194-200 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aAngiotensinogen _xgenetics |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aEnalapril _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKidney Transplantation |
| 650 | 0 | 4 |
_aLipid Peroxidation _xdrug effects |
| 650 | 0 | 4 |
_aLosartan _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMalondialdehyde _xblood |
| 650 | 0 | 4 |
_aPeptidyl-Dipeptidase A _xgenetics |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xgenetics |
| 650 | 0 | 4 |
_aRenin-Angiotensin System _xgenetics |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 700 | 1 | _aAghaeishahsavari, Mohammad | |
| 700 | 1 | _aArgani, Hassan | |
| 700 | 1 | _aNoroozianavval, Masood | |
| 700 | 1 | _aVeisi, Pegah | |
| 700 | 1 | _aGhorbanihaghjo, Amir | |
| 773 | 0 |
_tClinical biochemistry _gvol. 40 _gno. 3-4 _gp. 194-200 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.clinbiochem.2006.10.023 _zAvailable from publisher's website |
| 999 |
_c16787563 _d16787563 |
||